Archives of Medical Research
Volume 35, Issue 6 , Pages 495-498, November 2004

The hypotensive effect of BMY 7378 involves central 5-HT1A receptor stimulation in the adult but not in the young rat

  • Rafael Villalobos-Molina

      Affiliations

    • Departamento de Farmacobiología, Centro de Investigación y de Estudios Avanzados- IPN, Sede Sur, México City, México
    • Corresponding Author InformationAddress reprint requests to: Rafael Villalobos-Molina, Ph.D., Departamento de Farmacobiología, CINVESTAV-Sede Sur, Calz. Tenorios 235, Col. Granjas Coapa, México, D.F. 14330, México. Tel. (52 55)5061-2857; Fax. (52 55)5061-2863
  • ,
  • Miguel Gil-Flores

      Affiliations

    • Departamento de Farmacobiología, Centro de Investigación y de Estudios Avanzados- IPN, Sede Sur, México City, México
  • ,
  • Itzell A. Gallardo-Ortiz

      Affiliations

    • Departamento de Farmacobiología, Centro de Investigación y de Estudios Avanzados- IPN, Sede Sur, México City, México
  • ,
  • J. Javier López-Guerrero

      Affiliations

    • Departamento de Farmacobiología, Centro de Investigación y de Estudios Avanzados- IPN, Sede Sur, México City, México
  • ,
  • Maximiliano Ibarra

      Affiliations

    • Unidad de Biomedicina, Facultad de Estudios Superiores-Iztacala, Universidad Nacional Autónoma de México, México City, Mexico

Received 2 April 2004; accepted 16 July 2004.

(04/079)

Background

Stimulation of central 5-hydroxytryptamine-1A (5-HT1A) receptors produces hypotension and bradycardia. We describe BMY 7378 (8-[2-[4-(2-methoxyphenyl)-1-piperazinyl]ethyl]-8-azaspiro[4.5]decane-7,9 dione) effects in cardiovascular function and [3H] 8-OH-DPAT (8-hydroxy-2-(di-n-propyl-amino) tetralin) binding sites in rat brain of different ages.

Methods

BMY 7378 was administered to anesthetized male Wistar rats (1, 3 and 6 months old) and blood pressure and heart rate were continuously recorded. Saturation of [3H] 8-OH-DPAT binding to 5-HT1A sites in brain membranes was determined.

Results

Basal diastolic blood pressure increased with age, 85 ± 2, 106 ± 3, and 113 ± 2 mmHg for 1-, 3- and 6-month-old rats, respectively (p <0.05 among groups). BMY 7378 induced significant dose- and age-dependent hypotension. The selective 5-HT1A receptor antagonist, WAY 100635 (N-[2-[4-(2-methoxyphenyl)-1-piperazinyl]ethyl]N-(2-pyridinyl) cyclohexanecarboxamide), antagonized BMY 7378 effects in 6 month-old but not in younger rats. [3H] 8-OH-DPAT binding sites decreased in hippocampi and brainstem with maturation.

Conclusions

Data suggest that BMY 7378 is a hypotensive agent in the rat, but that its actions are mediated, in part, by central 5-HT1A receptor stimulation in the adult and by a nonserotonergic mechanism in the young rat.

Key words: 5-HT1A Receptors, BMY 7378, WAY 100635, Anesthetized rats, Blood pressure, Aging

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

PII: S0188-4409(04)00140-7

doi:10.1016/j.arcmed.2004.11.009

Archives of Medical Research
Volume 35, Issue 6 , Pages 495-498, November 2004